Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

著者: Stephen A. Harrison, Mustafa R. Bashir, Cynthia D. Guy, Rong Zhou, Cynthia A. Moylan, Juan P. Frías, Naim Alkhouri, Meena B. Bansal, Seth J. Baum, Brent A. Neuschwander‐Tetri, Rebecca Taub, Sam E. Moussa - The Lancet 2019 被引用: 765